InvestorsHub Logo
Post# of 252557
Next 10
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

Re: jbog post# 86425

Tuesday, 11/17/2009 9:07:15 AM

Tuesday, November 17, 2009 9:07:15 AM

Post# of 252557
pico in mCRC - The neurotoxicity profile for Pico is much better compared to Oxali based on ASCO presentation. So even a slightly equal efficacy should be good news for Pico. Median PFS was close in the data presented at ASCO. I think the CEO said they were going to present more PFS data today.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.